179 related articles for article (PubMed ID: 32675558)
1. Changes in gastrointestinal microbial communities influence HIV-specific CD8+ T-cell responsiveness to immune checkpoint blockade.
SahBandar IN; Chew GM; Corley MJ; Pang APS; Tsai N; Hanks N; Khadka VS; Klatt NR; Hensley-McBain T; Somsouk M; Vujkovic-Cvijin I; Chow DC; Shikuma CM; Ndhlovu LC
AIDS; 2020 Aug; 34(10):1451-1460. PubMed ID: 32675558
[TBL] [Abstract][Full Text] [Related]
2. Effects of Brief Adjunctive Metformin Therapy in Virologically Suppressed HIV-Infected Adults on Polyfunctional HIV-Specific CD8 T Cell Responses to PD-L1 Blockade.
Chew GM; Padua AJP; Chow DC; Souza SA; Clements DM; Corley MJ; Pang APS; Alejandria MM; Gerschenson M; Shikuma CM; Ndhlovu LC
AIDS Res Hum Retroviruses; 2021 Jan; 37(1):24-33. PubMed ID: 33019813
[TBL] [Abstract][Full Text] [Related]
3. Combination Immune Checkpoint Blockade Enhances IL-2 and CD107a Production from HIV-Specific T Cells Ex Vivo in People Living with HIV on Antiretroviral Therapy.
Chiu CY; Chang JJ; Dantanarayana AI; Solomon A; Evans VA; Pascoe R; Gubser C; Trautman L; Fromentin R; Chomont N; McMahon JH; Cameron PU; Rasmussen TA; Lewin SR
J Immunol; 2022 Jan; 208(1):54-62. PubMed ID: 34853078
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic and Functional Analyses Guiding Combination Immune Checkpoint Immunotherapeutic Strategies in HTLV-1 Infection.
Clements DM; Crumley B; Chew GM; Davis E; Bruhn R; Murphy EL; Ndhlovu LC; Jain P
Front Immunol; 2021; 12():608890. PubMed ID: 33767694
[TBL] [Abstract][Full Text] [Related]
5. Implications of Immune Checkpoint Expression During Aging in HIV-Infected People on Antiretroviral Therapy.
de Armas LR; Pallikkuth S; Rinaldi S; Pahwa R; Pahwa S
AIDS Res Hum Retroviruses; 2019; 35(11-12):1112-1122. PubMed ID: 31578868
[TBL] [Abstract][Full Text] [Related]
6. Reversal of the CD8
Li J; Huang HH; Tu B; Zhou MJ; Hu W; Fu YL; Li XY; Yang T; Song JW; Fan X; Jiao YM; Xu RN; Zhang JY; Zhou CB; Yuan JH; Zhen C; Shi M; Wang FS; Zhang C
Front Immunol; 2021; 12():687296. PubMed ID: 34177939
[TBL] [Abstract][Full Text] [Related]
7. Effects of Fecal Microbial Transplantation on Microbiome and Immunity in Simian Immunodeficiency Virus-Infected Macaques.
Hensley-McBain T; Zevin AS; Manuzak J; Smith E; Gile J; Miller C; Agricola B; Katze M; Reeves RK; Kraft CS; Langevin S; Klatt NR
J Virol; 2016 May; 90(10):4981-4989. PubMed ID: 26937040
[TBL] [Abstract][Full Text] [Related]
8. Mucosal cell populations may contribute to peripheral immune abnormalities in HIV-infected subjects introducing cART with moderate immune-suppression.
Basilissi M; Tincati C; Merlini E; Ancona G; Borghi E; Borgo F; Barassi A; d'Arminio Monforte A; Marchetti G
PLoS One; 2019; 14(2):e0212075. PubMed ID: 30763359
[TBL] [Abstract][Full Text] [Related]
9. Chang Wei Qing Decoction enhances the anti-tumor effect of PD-1 inhibitor therapy by regulating the immune microenvironment and gut microbiota in colorectal cancer.
Wang T; Wu L; Wang S; Shi X; Liu H; Deng W
Chin J Nat Med; 2023 May; 21(5):333-345. PubMed ID: 37245872
[TBL] [Abstract][Full Text] [Related]
10. Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection.
Mak G; Zaunders JJ; Bailey M; Seddiki N; Rogers G; Leong L; Phan TG; Kelleher AD; Koelsch KK; Boyd MA; Danta M
Front Immunol; 2021; 12():688886. PubMed ID: 34135912
[TBL] [Abstract][Full Text] [Related]
11. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
[No Abstract] [Full Text] [Related]
12. Molecular characterization of stool microbiota in HIV-infected subjects by panbacterial and order-level 16S ribosomal DNA (rDNA) quantification and correlations with immune activation.
Ellis CL; Ma ZM; Mann SK; Li CS; Wu J; Knight TH; Yotter T; Hayes TL; Maniar AH; Troia-Cancio PV; Overman HA; Torok NJ; Albanese A; Rutledge JC; Miller CJ; Pollard RB; Asmuth DM
J Acquir Immune Defic Syndr; 2011 Aug; 57(5):363-70. PubMed ID: 21436711
[TBL] [Abstract][Full Text] [Related]
13. The impact of immune checkpoint therapy on the latent reservoir in HIV-infected individuals with cancer on antiretroviral therapy.
Lau JSY; McMahon JH; Gubser C; Solomon A; Chiu CYH; Dantanarayana A; Chea S; Tennakoon S; Zerbato JM; Garlick J; Morcilla V; Palmer S; Lewin SR; Rasmussen TA
AIDS; 2021 Aug; 35(10):1631-1636. PubMed ID: 33859108
[TBL] [Abstract][Full Text] [Related]
14. Immune checkpoint expression on HIV-specific CD4+ T cells and response to their blockade are dependent on lineage and function.
Brunet-Ratnasingham E; Morou A; Dubé M; Niessl J; Baxter AE; Tastet O; Brassard N; Ortega-Delgado G; Charlebois R; Freeman GJ; Tremblay C; Routy JP; Kaufmann DE
EBioMedicine; 2022 Oct; 84():104254. PubMed ID: 36150362
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiome affects the response to immunotherapy in non-small cell lung cancer.
Ren S; Feng L; Liu H; Mao Y; Yu Z
Thorac Cancer; 2024 May; 15(14):1149-1163. PubMed ID: 38572783
[TBL] [Abstract][Full Text] [Related]
16. Alterations in the gut microbiota of patients with acquired immune deficiency syndrome.
Zhou Y; Ou Z; Tang X; Zhou Y; Xu H; Wang X; Li K; He J; Du Y; Wang H; Chen Y; Nie Y
J Cell Mol Med; 2018 Apr; 22(4):2263-2271. PubMed ID: 29411528
[TBL] [Abstract][Full Text] [Related]
17. Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection.
Schunter M; Chu H; Hayes TL; McConnell D; Crawford SS; Luciw PA; Bengmark S; Asmuth DM; Brown J; Bevins CL; Shacklett BL; Critchfield JW
BMC Complement Altern Med; 2012 Jun; 12():84. PubMed ID: 22747752
[TBL] [Abstract][Full Text] [Related]
18. Oral and Gut Microbial Diversity and Immune Regulation in Patients with HIV on Antiretroviral Therapy.
Annavajhala MK; Khan SD; Sullivan SB; Shah J; Pass L; Kister K; Kunen H; Chiang V; Monnot GC; Ricupero CL; Mazur RA; Gordon P; de Jong A; Wadhwa S; Yin MT; Demmer RT; Uhlemann AC
mSphere; 2020 Feb; 5(1):. PubMed ID: 32024712
[TBL] [Abstract][Full Text] [Related]
19. Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients.
Derosa L; Routy B; Fidelle M; Iebba V; Alla L; Pasolli E; Segata N; Desnoyer A; Pietrantonio F; Ferrere G; Fahrner JE; Le Chatellier E; Pons N; Galleron N; Roume H; Duong CPM; Mondragón L; Iribarren K; Bonvalet M; Terrisse S; Rauber C; Goubet AG; Daillère R; Lemaitre F; Reni A; Casu B; Alou MT; Alves Costa Silva C; Raoult D; Fizazi K; Escudier B; Kroemer G; Albiges L; Zitvogel L
Eur Urol; 2020 Aug; 78(2):195-206. PubMed ID: 32376136
[TBL] [Abstract][Full Text] [Related]
20. Limited engraftment of donor microbiome via one-time fecal microbial transplantation in treated HIV-infected individuals.
Vujkovic-Cvijin I; Rutishauser RL; Pao M; Hunt PW; Lynch SV; McCune JM; Somsouk M
Gut Microbes; 2017 Sep; 8(5):440-450. PubMed ID: 28541799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
